Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,209,500 papers from all fields of science
Search
Sign In
Create Free Account
rgp 160
Known as:
immuno rgp 160
, rgp160
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
VaxSyn HIV-1 (gp160) vaccine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Effects of organic acid supplementation on antioxidant capacity and immune responses of broilers challenged orally with Salmonella enterica subsp. enterica Typhimurium
A. Abudabos
,
S. Al-Mufarrej
2015
Corpus ID: 55514439
Four commercial organic acids and a reference antibiotic, Neoxyval, were administered to commercial broilers to evaluate the…
Expand
2014
2014
A Broadcast-Based Key Agreement Scheme Using Set Reconciliation for Wireless Body Area Networks
Aftab Ali
,
F. A. Khan
Journal of medical systems
2014
Corpus ID: 6675731
Information and communication technologies have thrived over the last few years. Healthcare systems have also benefited from this…
Expand
2014
2014
Phenotypic and Genotypic Characterization of Nosocomial Isolates of Staphylococcus aureus with Reference to Methicillin Resistance
M. Salem-Bekhit
2014
Corpus ID: 26249749
Purpose : To investigate the occurrence, species prevalence, antibacterial resistance, and molecular characteristics of S. aureus…
Expand
2013
2013
Effectiveness of zinc in modulating perinatal effects of arsenic on the teratological effects in mice offspring.
Mohammad Ahmad
,
Mohammad A M Wadaa
,
Muhammad Farooq
,
M. Daghestani
,
A. Sami
Biological Research
2013
Corpus ID: 14209583
Exposure to arsenic via drinking water is considered as a worldwide problem. Studies have shown that arsenic exposure during…
Expand
2012
2012
Heterocyclic compounds based on 3-(4-bromophenyl) azo-5-phenyl-2(3H)-furanone: Anti-avian influenza virus (H5N1) activity / Heterociklički derivati 3-(4-bromfenil) azo-5-fenil-2(3H)-furanona…
E. M. Flefel
,
R. E. Abdel-Mageid
,
Waled A. Tantawy
,
Mohamed A. Ali
,
A. Amr
Acta Pharmaceutica
2012
Corpus ID: 10059214
1 3-[2-(4-Bromphenyl)hydrazono]-5-phenyl-furan-2(3H)-one () was used for preparation of some novel pyrazole, pyridazinone…
Expand
2007
2007
Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
R. Hu
,
Y. Liu
,
S. Zhang
,
F. Zhang
,
A. Fooks
Vaccine
2007
Corpus ID: 19517026
2002
2002
Loss of heterozygosity, microsatellite instability, and mismatch repair protein alterations in the radial growth phase of cutaneous malignant melanomas
M. Hussein
,
Min Sun
,
+4 authors
O. Sudilovsky
Molecular Carcinogenesis
2002
Corpus ID: 36667232
Little is known about genomic alterations during development of the radial growth phase (RGP) of cutaneous malignant melanomas…
Expand
Highly Cited
1993
Highly Cited
1993
Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles.
Guy T. Layton
,
S. Harris
,
+6 authors
Sally E. Adams
Journal of Immunology
1993
Corpus ID: 27295657
In general, it has proven difficult to induce CTL responses using simple proteins or peptides without resorting to specialized…
Expand
1993
1993
Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines.
C. de Santis
,
P. Robbioni
,
+4 authors
N. Roberts
Journal of Infectious Diseases
1993
Corpus ID: 42173922
Autoantibodies specific to HLA class I antigens were detected in the sera of persons vaccinated with human immunodeficiency virus…
Expand
1992
1992
The interaction of a glycosaminoglycan, heparin, with HIV-1 major envelope glycoprotein.
E. Mbemba
,
J. Czyrski
,
L. Gattegno
Biochimica et Biophysica Acta
1992
Corpus ID: 30855496
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE